by author1 | Oct 16, 2025 | Unkategorisiert
Those who develop digital offerings for health promotion or prevention often face the question: How can these be financed through health insurance companies? Many software manufacturers are familiar with the reimbursement options available through DiGA. Much less well...
by Sabine | May 15, 2025 | diga-whitepaper, Unkategorisiert
In 2020, Germany became the first country to establish DiGA in regular healthcare. This means that digital health applications can be approved in a structured, transparent process. Once approved, DiGA can then be prescribed by doctors in a similar way to medication....
by Daniel Lange | Feb 5, 2025 | medical-software-whitepaper, Unkategorisiert
Over the past ten years, we have learned a great deal about the development of software medical devices. We are pleased to share this expertise in our technical articles with (prospective) developers of Software as a Medical Device (SaMD) so that not everyone has to...
by Alexander Fenkiw | Jan 9, 2025 | medical-software-whitepaper, Unkategorisiert
At the beginning of the development of a software medical device, the central question is: Which risk class applies to my product? Risk classification has serious implications and significantly influences the cost and time frame of product development. In extreme...
by Alexander Fenkiw | Sep 18, 2024 | Unkategorisiert
On December 19, 2019, the Digital Care Act (DVG) made it possiblethat doctors can now prescribe digital health applications (DiGA) to patients in a standardized way for the first time. A counterpart to this has also been created for nursing care: digital care...
by Malte Bucksch | Sep 10, 2024 | Unkategorisiert
The implementation of a digital health application (DiGA) involves effort and costs that should ultimately be worthwhile for your company. And indeed – many certified DiGAs that make it onto the market show extremely positive prescription and sales figures....